Marietta Landgraf

Marietta Landgraf

Auto-generated profile, based on publicly available information

Marietta Landgraf

Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, QLD 4059, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Trends in Biotechnology
Verified
Journal Article
Closed access
MLMarietta Landgraf
Marietta Landgraf
JMJacqui A. McGovern
Jacqui A. McGovern
PFPeter Friedl
Peter Friedl
Dietmar Werner HutmacherDietmar Werner Hutmacher
Dietmar Werner Hutmacher

16 April 2018 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
ASAbbas Shafiee
Abbas Shafiee
JMJacqui A. McGovern
Jacqui A. McGovern
CLChristoph A. Lahr
Christoph A. Lahr
CMChristoph Meinert
Christoph Meinert
DMDavide Moi
Davide Moi
Dietmar Werner HutmacherDietmar Werner Hutmacher
Dietmar Werner Hutmacher

1 December 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
CLChristoph A. Lahr
Christoph A. Lahr
MLMarietta Landgraf
Marietta Landgraf
ASAlvaro Sanchez-Herrero
Alvaro Sanchez-Herrero
HDHoang Phuc Dang
Hoang Phuc Dang
Ferdinand WagnerFerdinand Wagner
Ferdinand Wagner
Dietmar Werner HutmacherDietmar Werner Hutmacher
Dietmar Werner Hutmacher

21 October 2019 in Bone Research
Verified
Journal Article
Open access
PDF file
MLMarietta Landgraf
Marietta Landgraf
CLChristoph A. Lahr
Christoph A. Lahr
ASAlvaro Sanchez-Herrero
Alvaro Sanchez-Herrero
Christoph MeinertChristoph Meinert
Christoph Meinert
ASAli Shokoohmand
Ali Shokoohmand
JMJacqui McGovern
Jacqui McGovern
Advanced prostate cancer (PCa) is known for its high prevalence to metastasize to bone, at which point it is considered incurable. Despite significant effort, there is no animal model capable of recapitulating the complexity of PCa bone metastasis. The humanized mouse model for PCa bone metastasis used in this study aims to provide a platform for the assessment of new drugs by recapitulating the human–human cell interactions relevant for disease development and progression. The humanized tissue-engineered bone construct (hTEBC) was created within NOD-scid IL2rgnull (NSG) mice and was used for the study of experimental PC3-Luc bone metastases. It was confirmed that PC3-Luc cells preferentially grew in the hTEBC compared with murine bone. The translational potential of the humanized mouse model for PCa bone metastasis was evaluated with two clinically approved osteoprotective therapies, the non-species-specific bisphosphonate zoledronic acid (ZA) or the human-specific antibody Denosumab, both targeting Receptor Activator of Nuclear Factor Kappa-Β Ligand. ZA, but not Denosumab, significantly decreased metastases in hTEBCs, but not murine femora. These results highlight the importance of humanized models for the preclinical research on PCa bone metastasis and indicate the potential of the bioengineered mouse model to closely mimic the metastatic cascade of PCa cells to human bone. Eventually, it will enable the development of new effective antimetastatic treatments.

13 November 2018 in Cancers
Verified
Journal Article
Open access
PDF file
JMJacqui McGovern
Jacqui McGovern
ASAbbas Shafiee
Abbas Shafiee
Ferdinand WagnerFerdinand Wagner
Ferdinand Wagner
CLChristoph A. Lahr
Christoph A. Lahr
MLMarietta Landgraf
Marietta Landgraf
Dietmar Werner HutmacherDietmar Werner Hutmacher
Dietmar Werner Hutmacher
The primary tumor microenvironment is inherently important in prostate cancer (PCa) initiation, growth and metastasis. However, most current PCa animal models are based on the injection of cancer cells into the blood circulation and bypass the first steps of the metastatic cascade, hence failing to investigate the influence of the primary tumor microenvironment on PCa metastasis. Here, we investigated the spontaneous metastasis of PC3 human PCa cells from humanized prostate tissue, containing cancer-associated fibroblasts (CAFs) and prostate lymphatic and blood vessel endothelial cells (BVECs), to humanized tissue-engineered bone constructs (hTEBCs) in NOD-SCID IL2Rγnull (NSG) mice. The hTEBC formed a physiologically mature organ bone which allowed homing of metastatic PCa cells. Humanization of prostate tissue had no significant effect on the tumor burden at the primary site over the 4 weeks following intraprostatic injection, yet reduced the incidence and burden of metastases in the hTEBC. Spontaneous PCa metastases were detected in the lungs and spleen with no significant differences between the humanized and non-humanized prostate groups. A significantly greater metastatic tumor burden was observed in the liver when metastasis occurred from the humanized prostate. Together, our data suggests that the presence of human-derived CAFs and BVECs in the primary PCa microenvironment influences selectively the metastatic and homing behavior of PC3 cells in this model. Our orthotopic and humanized PCa model developed via convergence of cancer research and tissue engineering concepts provides a platform to dissect mechanisms of species-specific PCa bone metastasis and to develop precision medicine strategies.

1 January 2017
Verified
Journal Article
Closed access
NHNina Pauline Holzapfel
Nina Pauline Holzapfel
ASAli Shokoohmand
Ali Shokoohmand
FWFerdinand Wagner
Ferdinand Wagner
MLMarietta Landgraf
Marietta Landgraf
SCSimon Champ
Simon Champ
Daniela LoessnerDaniela Loessner
Daniela Loessner